Advanced Medicine Partners is dedicated to forging a new benchmark in the creation and assessment of groundbreaking medicines. Our mission is to transform the landscape of patient care and family well-being through cutting-edge therapies. We specialize in delivering comprehensive services, encompassing process development, manufacturing, and rigorous analytical testing tailored for advanced therapy medicinal products, with a particular emphasis on gene therapies.
Our expertise spans a broad spectrum of platforms and modalities, ensuring we can meet the diverse needs of our partners. This includes proficiency in adeno-associated virus (AAV), lentivirus, and various other delivery systems critical to advanced medicine. At the heart of Advanced Medicine Partners is a team recognized as one of the most seasoned in the genetic medicines sector. Our team’s deep industry knowledge permeates every level of our operation, from laboratory innovation to strategic boardroom decisions. Our exclusive manufacturing platform consistently achieves industry-leading yields and exceptional purity profiles, pushing the boundaries of what is achievable in advanced medicine manufacturing.
The company’s proprietary adeno-associated virus (AAV) manufacturing process is engineered to minimize both process and product-related impurities. This advanced approach consistently yields industry-leading functional full capsid ratios and best-in-class production efficiencies. Our commitment to innovation in advanced medicine is rooted in a patient-first philosophy, ensuring the highest standards of safety while also focusing on reducing the cost of goods. Advanced Medicine Partners is committed to setting a new standard that not only meets but exceeds the expectations of regulatory agencies and, most importantly, the needs of patients.
Building upon extensive operational experience gained from Jaguar Gene Therapy and other prominent biotechnology firms, the Advanced Medicine Partners team brings a wealth of practical knowledge to every project. Collectively, our team has an impressive track record, having manufactured over 350 non-GMP batches and supported more than 20 preclinical studies. This includes pivotal initial new drug application (IND) enabling efficacy and good laboratory practice (GLP) toxicology studies, underscoring our deep expertise in advanced medicine development.
What truly sets Advanced Medicine Partners apart from traditional CDMOs is our distinct partnership philosophy. Unlike conventional contract development and manufacturing organizations that often operate at arm’s length from their clients, we embed ourselves as an extension of our client’s own capabilities. We function as your extended workbench, strategically removing CMC (Chemistry, Manufacturing, and Controls) activities from the critical path of development. Furthermore, we empower our partners with real-time data access, facilitating informed decision-making and significantly accelerating their advanced therapy programs. Partner with Advanced Medicine Partners to drive your innovations in advanced medicine forward, faster and more efficiently.
